XML 39 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Equity-Based Compensation
6 Months Ended
Jun. 30, 2013
Share-based Compensation [Abstract]  
Equity-Based Compensation
EQUITY-BASED COMPENSATION
As of June 30, 2013, we had three stock incentive plans under which performance share grants, restricted stock unit (RSU) grants and stock options were outstanding, with approximately 260,000 shares authorized for future use under the 2005 Stock Incentive Plan.
The following table details our equity-based compensation expense and director deferred compensation expense (income) for the quarters and six months ended June 30:
 
 
Quarter Ended June 30,
 
Six Months Ended June 30,
 
 
(Dollars in thousands)
2013
 
2012
 
2013
 
2012
Employee equity-based compensation expense:
 
 
 
 
 
 
 
Performance shares
$
891

 
$
892

 
$
1,753

 
$
1,707

Restricted stock units
138

 
159

 
348

 
291

Total employee equity-based compensation expense
$
1,029

 
$
1,051

 
$
2,101

 
$
1,998

 
 
 
 
 
 
 
 
Actual tax benefit realized for tax deductions from equity-based plans
$
48

 
$

 
$
71

 
$

 
 
 
 
 
 
 
 
Director deferred compensation expense (income)
$
(940
)
 
$
184

 
$
350

 
$
427


PERFORMANCE SHARES
The following table presents the key inputs used in the Monte Carlo simulation method to calculate the fair value of the performance share awards in 2013 and 2012, and the resulting fair values:
 
2013
 
2012
Shares granted
83,111

 
85,028

Stock price as of valuation date
$
45.31

 
$
31.11

Risk-free rate
0.40
%
 
0.40
%
Fair value of a performance share
$
62.78

 
$
34.24



The following table summarizes outstanding performance share awards as of June 30, 2013, and changes during the six months ended June 30, 2013:
(Dollars in thousands, except grant date fair value)
Shares
 
Weighted Avg.
Grant Date
Fair Value
 
Aggregate
Intrinsic Value
Unvested shares outstanding at January 1
160,214

 
$
44.50

 
 
Granted
83,111

 
62.78

 
 
Forfeited
(10,786
)
 
45.83

 
 
Unvested shares outstanding at June 30
232,539

 
50.97

 
$
9,097


As of June 30, 2013, there was $6.1 million of unrecognized compensation cost related to unvested performance share awards, which is expected to be recognized over a weighted average period of 1.5 years.
RESTRICTED STOCK UNITS
The following table summarizes outstanding RSU awards as of June 30, 2013, and changes during the six months ended June 30, 2013:
(Dollars in thousands, except grant date fair value)
Shares
 
Weighted Avg.
Grant Date
Fair Value
 
Aggregate
Intrinsic Value
Unvested shares outstanding at January 1
40,219

 
$
34.82

 
 
Granted
18,949

 
45.43

 
 
Vested
(3,100
)
 
36.60

 
 
Forfeited
(5,410
)
 
35.83

 
 
Unvested shares outstanding at June 30
50,658

 
38.57

 
$
2,049


For RSU awards granted during the period, the fair value of each unit was determined on the date of grant using the grant date market price. The total fair value of RSU awards vested during the six months ended June 30, 2013 was $0.1 million. As of June 30, 2013, there was $1.0 million of total unrecognized compensation cost related to non-vested RSU awards, which is expected to be recognized over a weighted average period of 1.3 years.
STOCK OPTIONS
The following table summarizes outstanding stock options as of June 30, 2013, and changes during the six months ended June 30, 2013:
(Dollars in thousands, except exercise prices)
Shares
 
Weighted Avg.
Exercise Price
 
Aggregate
Intrinsic Value
Outstanding at January 1
83,827

 
$
27.46

 
 
Shares exercised
(65,461
)
 
27.47

 
$
1,312

Shares canceled or expired

 

 
 
Outstanding and exercisable at June 30
18,366

 
27.42

 
239


Cash received from stock options exercised during the six months ended June 30, 2013 and 2012 was $1.8 million and $0.1 million, respectively. There were no unvested stock options outstanding during the six months ended June 30, 2013. The aggregate intrinsic value of stock options exercised during the six months ended June 30, 2012 was $0.1 million.
The following table summarizes outstanding stock options as of June 30, 2013:
 
Options Outstanding and Exercisable
Range of Exercise Prices
Outstanding
 
Weighted Avg.
Remaining
Contractual Life
$19.2569
5,507

 
0.42 years
$30.9204
12,859

 
1.42 years
 
18,366

 
1.12 years